A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Drug Acquiring Traction Online
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a flourishing market exists on Telegram, where communities with thousands of participants share comparison images, administration instructions and assertions of rapid British shipping. Sellers market the substance there before redirecting customers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could help patients reduce up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Healthcare Experts Voice Worries
However, doctors and pharmacists have warned that the distribution of what is still an unlicensed medication in the UK is a cause for concern and could result in users injecting substances of uncertain source.
Several professionals said the popularity for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or prison.
Service Reaction and Content Removal
Based on TikTok, the platform has removed problematic material and prohibited related hashtags and query recommendations. The organization stated it was committed to keeping the service secure and allocating resources in enhancing compliance measures.
Digital Marketplace Activities
Investigations also found communities with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately brings up groups with numerous of users, filled with images of slimming results, positive reviews and step-by-step instructions for mixing or injecting at residence.
Within moments of joining one group, a vendor posted contact information, where most purchases take place. The seller provided an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or past usage.
Product Information and Pricing
Within these communities, posts show dark colored packages with postal service stickers, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens typically priced at £160 for 20 milligrams. When asked how long a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Security Actions
A representative for the messaging service said it actively moderated dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“People are administering substances they cannot confirm. Although the science behind retatrutide is sound, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was sterile,” she said.
Her staff has already encountered patients harmed by personal administration from unconfirmed sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said the substance was in third stage research studies and had not been reviewed or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational product not yet authorized … may subject patients to possibly serious medical dangers”.
